Family Capital Trust’s Biogen BIIB Stock Holding History

Family Capital Trust’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-25	Closed	-$10K	–	90
2015 Q2	$10K	Buy	+25	New	+$10K	0.01%	99

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Family Capital Trust's BIIB Position: Q3 2015 in Review

Family Capital Trust sold out of Biogen (BIIB) in Q3 2015, closing a stake of 25 shares — an estimated $10K sold.

Family Capital Trust first reported a position in BIIB in Q2 2015 and held it in 1 quarter. The position peaked at $10K in Q2 2015. 924 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

Family Capital Trust reported no remaining Biogen position as of Q3 2015 after selling out during the quarter.
Family Capital Trust sold 25 Biogen shares in Q3 2015, an estimated $10K.
Family Capital Trust first reported a position in Biogen in Q2 2015 and held it in 1 quarter.
Family Capital Trust's Biogen position peaked at $10K in Q2 2015.
924 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on Family Capital Trust's 13F filing for Q3 2015, filed 21 Oct 2015.